Cargando…
Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy
BACKGROUND: Circulating tumour DNA from colorectal cancer (CRC) is a biomarker for early detection of the disease and therefore potentially useful for screening. One such biomarker is the methylated SEPT9 (mSEPT9) gene, which occurs during CRC tumourigenesis. This systematic review and meta-analysis...
Autores principales: | Hariharan, Rohit, Jenkins, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039590/ https://www.ncbi.nlm.nih.gov/pubmed/32128229 http://dx.doi.org/10.1136/bmjgast-2019-000355 |
Ejemplares similares
-
Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome
por: Hitchins, Megan P, et al.
Publicado: (2019) -
Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical planes in patients with early rectal cancer
por: Balyasnikova, Svetlana, et al.
Publicado: (2017) -
Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot
por: Saw, Kai Sheng, et al.
Publicado: (2023) -
Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold
por: Young, Graeme P, et al.
Publicado: (2020) -
Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening
por: Liedenbaum, M H, et al.
Publicado: (2009)